Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic antipyretics with Synflorix booster plus Infanrix hexa in toddlers
2006-001481-17Phase 3Completed
- Sponsor
- GSK
- Start
- Mar 2007
- Modality
- Small Molecules, Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of 10-valent pneumococcal conjugate vaccine, pertussis filamentous haemagglutinin, acetaminophen and meningococcal conjugate vaccine in pneumococcal disease and meningococcal disease (3 arms), sponsored by GSK. Primary endpoint: Occurrence of fever after booster vaccination. Started Mar 2007; status: completed.
02
Drugs
10-valent pneumococcal conjugate vaccinepertussis filamentous haemagglutininacetaminophenmeningococcal conjugate vaccine
03
Conditions
pneumococcal diseasemeningococcal disease
Beyond the preview
Go deeper on 2006-001481-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001481-17.